[On the mailing list: use of acyclovir in patients on hemodialysis].

Author: D'AmicoM, FraticelliM, LimidoA

Paper Details 
Original Abstract of the Article :
In the SIN Mailing List a message published in May 2004 gave rise to an interesting debate as to the use and dosage of acyclovir in dialysis patients for the treatment of varicella-zoster infection, considering the side effects (mainly neurological) reported in patients affected by renal insufficien...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/15786379

データ提供:米国国立医学図書館(NLM)

Acyclovir in Dialysis Patients: A Balancing Act of Risks and Benefits

Acyclovir is a powerful antiviral medication used to treat infections caused by the herpes virus. However, when it comes to patients with kidney disease, the use of acyclovir can be tricky. This article discusses a debate that emerged regarding the use and dosage of acyclovir in patients on dialysis. The main concern revolves around the potential neurological side effects of acyclovir, which can be more pronounced in patients with impaired kidney function. The authors provide a balanced overview of the pharmacological characteristics of acyclovir, its clinical indications, and the available evidence on its side effects in patients with kidney disease.

Navigating Treatment for Herpes Infections

The article suggests that, in cases of severe kidney insufficiency, the use of acyclovir should be avoided unless absolutely necessary. When acyclovir is considered, it's essential to monitor the patient closely for any signs of neurotoxicity. The authors also point out that there's limited data on the use of newer antiviral drugs, like famciclovir and brivudine, in dialysis patients, highlighting the need for further research in this area.

Considering Risks and Benefits

This article underscores the importance of carefully weighing the risks and benefits of medications, particularly for patients with complex medical conditions. Doctors must consider the individual patient's needs, the severity of the infection, and the potential risks associated with the medication. This is especially important when treating patients with kidney disease, as their bodies may be more susceptible to adverse effects.

Dr. Camel's Conclusion

Treating patients with kidney disease can be like navigating a treacherous sandstorm; you need to proceed with caution and make calculated decisions. This article highlights the need for continued research to develop safer and more effective treatments for herpes infections in patients with impaired kidney function.

Date :
  1. Date Completed 2005-04-14
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

15786379

DOI: Digital Object Identifier

15786379

Related Literature

SNS
PICO Info
in preparation
Languages

Italian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.